Hepatitis C virus transmission among people who inject drugs in rural United States: mathematical modeling study using stochastic agent-based network simulation - Report - MDSpire

Hepatitis C virus transmission among people who inject drugs in rural United States: mathematical modeling study using stochastic agent-based network simulation

  • By

  • Lin Zhu

  • Jennifer R Havens

  • Abby E Rudolph

  • April M Young

  • Golnaz Eftekhari Yazdi

  • William W Thompson

  • Liesl M Hagan

  • Liisa M Randall

  • Jianing Wang

  • Rebecca Earnest

  • Shayla Nolen

  • Benjamin P Linas

  • Joshua A Salomon

  • July 17, 2025

  • 0 min

Share

Modeling HCV Spread Among Rural PWID Using Agent-Based Network Simulation

Overview

This study developed an agent-based network simulation model to examine hepatitis C virus (HCV) transmission among people who inject drugs (PWID) in rural America. Key network properties such as HCV prevalence, average number of injection partners, and homophily significantly influenced overall HCV incidence and risk heterogeneity. The findings highlight the importance of considering network structure in designing targeted interventions.

Background

Hepatitis C virus infection affects approximately 2.4 million adults in the United States, with injection drug use being the primary transmission route. Rural areas have experienced emerging HCV epidemics linked to injection drug use, despite higher absolute numbers in urban settings. Direct-acting antiviral treatments offer effective cure options but are costly, underscoring the need for optimized prevention strategies. Mathematical and network-based models can elucidate transmission dynamics and inform intervention design among PWID populations.

Data Highlights

ParameterSource/Description
Population287 PWID from SNAP study in rural Eastern Kentucky
Data CollectionRDS recruitment, baseline and 2-year follow-up
Network SizeUp to 24 reported injection partners per participant
HCV PrevalenceCalibrated from empirical data and literature
Simulation ApproachStochastic agent-based network model of injection equipment sharing

Key Findings

  • HCV acquisition risk among PWID is highly heterogeneous, quantified by the Gini coefficient.
  • PWID with fewer injection partners have lower individual incidence but collectively acquire more infections due to their larger numbers.
  • Higher HCV prevalence, greater average number of injection partners, and stronger homophily in infection status reduce risk heterogeneity and increase overall incidence.
  • Other network properties, including population size, have minimal impact on HCV incidence and risk distribution.
  • Network structure critically influences the effectiveness of treatment-as-prevention strategies.

Clinical Implications

Understanding the heterogeneity in HCV transmission risk among PWID can guide more effective targeting of prevention and treatment interventions. Measuring key network properties such as partner number and infection homophily in rural PWID populations may improve the design and implementation of harm reduction and antiviral treatment programs. Tailoring strategies to network dynamics could enhance efforts toward HCV elimination in rural settings.

Conclusion

This study demonstrates that network characteristics substantially shape HCV transmission dynamics among rural PWID. Incorporating these factors into intervention planning may optimize prevention and control efforts in this vulnerable population.

References

  1. Centers for Disease Control and Prevention 2021 -- Hepatitis C Virus Infection Statistics
  2. Social Networks among Appalachian People (SNAP) Study -- Data Source for Rural PWID Networks
  3. Agent-Based Network Modeling Studies -- Impact on HCV Transmission Dynamics

Original Source(s)

Related Content